BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $28.5M invested in BioLineRX in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $34.9M → $28.5M (-$6.4M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$147K | |
| 2 | +$93K | |
| 3 | +$63.7K | |
| 4 |
Morgan Stanley
New York
|
+$31.4K |
| 5 |
VanEck Associates
New York
|
+$31K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$1.1M | |
| 3 | -$168K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$164K |
| 5 |
Renaissance Technologies
New York
|
-$126K |